| Variables | HIV− n (%) | HIV+ n (%) | Total |
| Hb | |||
| ≤10 g/dL | 1 (7.1%) | 0 (0.0%) | 1 (7.1%) |
| >10 - 13 g/dL | 7 (50.0%) | 6 (42.9%) | 13 (46.4%) |
| >13 g/dL | 6 (42.9%) | 8 (57.1%) | 14 (50.0%) |
| Total | 14 (100.0%) | 14 (100.0%) | 28 (100.0%) |
| WBC | |||
| <4000 elts/mm3 | 6 (42.9%) | 3 (21.4%) | 9 (32.1%) |
| 4000 - 10,000 elts/mm3 | 8 (57.1%) | 11 (78.6%) | 19 (67.9%) |
| Total | 14 (100%) | 14 (100%) | 28 (100%) |
| WBC differential | |||
| Predominantly lymphocytic | 14 (100.0%) | 14 (100.0%) | 28 (100.0%) |
| Total | 14 (100.0%) | 14 (100.0%) | 28 (100.0%) |
| CRP | |||
| 0 - 6 mg/dL | 13 (92.9%) | 12 (85.7%) | 25 (89.3%) |
| >6 mg/dL | 1 (7.1%) | 2 (14.3%) | 3 (10.7%) |
| Total | 14 (100.0%) | 14 (100.0%) | 28 (100.0%) |
| GOT | |||
| 0 - 31 UI/L | 12 (85.7%) | 10 (71.4%) | 22 (78.6%) |
| >31 UI/L | 2 (14.3%) | 4 (28.6%) | 6 (21.4%) |
| Total | 14 (100.0%) | 14 (100.0%) | 28 (100.0%) |
| GPT | |||
| 0 - 41 UI/L | 13 (92.9%) | 13 (92.9%) | 26 (92.9%) |
| >41 UI/L | 1 (7.1%) | 1 (7.1%) | 2 (7.1%) |
| Total | 14 (100.0%) | 14 (100.0%) | 28 (100.0%) |
| HDL | |||
| <30 mg/dL | 1 (7.1%) | 2 (14.3%) | 3 (10.7%) |
| 30 - 60 mg/dL | 10 (71.4%) | 11 (78.6%) | 21 (75.0%) |
| >60 mg/Dl | 3 (21.4%) | 1 (7.1%) | 4 (14.3%) |
| Total | 14 (100.0%) | 14 (100.0%) | 28 (100.0%) |
| LDL | |||
| <160 mg/dL | 12 (85.7%) | 13 (92.9%) | 25 (89.3%) |
| >160 mg/dL | 2 (14.3%) | 1 (7.1%) | 3 (10.7%) |
| Total | 14 (100.0%) | 14 (100.0%) | 28 (100.0%) |
| TOTAL PROTEINS | |||
| <6.6 g/dL | 2 (14.3%) | 1 (7.1%) | 3 (10.7%) |
| 6.6 - 8.2 g/dL | 11 (78.6%) | 13 (92.9%) | 24 (85.7%) |
| >8.2 g/dL | 1 (7.1%) | 0 (0.0%) | 1 (3.6%) |
| Total | 14 (100.0%) | 14 (100.0%) | 28 (100.0%) |